Pregnancy
Insulin is the only proven-safe antihyperglycemic agent. Does not cross placenta. Lispro and aspart preferred rapid-acting agents. Requirements double by third trimester, fall abruptly post-delivery.
Critical Care / Perioperative
Target glucose 140–180 mg/dL. Basal at 75–80% of usual dose; bolus held while fasting. Intravenous regular insulin for major surgery or intensive care unit. NICE-SUGAR: intensive control (81–108) increased mortality.
Renal Impairment
Reduced insulin clearance prolongs action. Dose reduction required as estimated glomerular filtration rate falls below 30 mL/min. Hypoglycemia risk increases significantly.